A comparison of metacognitive factors among patients with cancer and the control group

Psycho-oncology
Hasan Huseyin MutluMahmut Gumus

Abstract

Research examining the relationship between metacognitions and cancer has only recently begun to emerge. This study attempted to compare the metacognitions of the patients with and without cancer. The effects of stage of cancer, type of cancer, and treatment modality (chemotherapy, radiotherapy, operation) on metacognitions were investigated. Patients with cancer were hypothesized to have higher levels of negative metacognitions. Participants were patients with cancer (N = 279) and patients without cancer (control group, N = 212). The Metacognition Questionnaire-30 was administered to all participants. Results were analyzed according to demographic and histopathological characteristics of the patients. The results showed that patients with different cancer diagnoses scored higher than the controls on all subscales of the MCQ-30. Those who received chemotherapy scored the highest on the MCQ-30. The patients who were in early stages of cancer had higher levels of negative metacognitions. Patients who did not have operation but had chemotherapy had the highest levels of negative metacognitions. Patients who were in locally advanced stage, did not have operation but had received or was receiving chemotherapy had the highest levels ...Continue Reading

References

Nov 1, 1994·Behaviour Research and Therapy·A Wells, A P Morrison
Jan 21, 2000·Behavior Modification·G Matthews, A Wells
Dec 8, 2000·Psychosomatics·H M ChochinovS Lander
Mar 5, 2004·Patient Education and Counseling·Sophia Rosman
Mar 5, 2004·Behaviour Research and Therapy·Adrian Wells, Sam Cartwright-Hatton
Jul 21, 2004·Journal of the National Cancer Institute. Monographs·Mary Jane Massie
Oct 22, 2005·BMJ : British Medical Journal·Nigel Hunt, Sue McHale
Jan 31, 2006·Psycho-oncology·Barry D Bultz, Linda E Carlson
Sep 28, 2006·World Journal of Surgical Oncology·Manoj PandeyRita Krishnan
Aug 4, 2007·Breast Cancer Research and Treatment·M ReichC Perdrizet-Chevallier
May 20, 2008·Psycho-oncology·Marieke H J van den Beuken-van EverdingenJacob Patijn
May 22, 2008·Nature Clinical Practice. Oncology·Yoichi ChidaAndrew Steptoe
Sep 8, 2009·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Winnie K W SoGeorge K H Li
Dec 17, 2009·Clinical Psychology Review·Josh M Cisler, Ernst H W Koster
Apr 13, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Bianca SenfJochen Kaiser
Jun 1, 1996·Journal of Clinical Psychology in Medical Settings·D L MillerJ Dougherty
Apr 24, 2014·Depression and Anxiety·Nicoline NormannNexhmedin Morina
Jul 22, 2014·Psycho-oncology·Enrico ToffaliniCesare Cornoldi
Dec 11, 2014·Revista latino-americana de enfermagem·Bianca Fresche de SouzaAdriana Inocenti Miasso
Mar 6, 2015·Palliative & Supportive Care·Yu-Chan LiChun-Kai Fang

❮ Previous
Next ❯

Citations

Sep 11, 2020·Behavioral Sciences·Jessica RanieriDina Di Giacomo
Jan 31, 2020·Frontiers in Psychology·Vittorio LenzoMaria C Quattropani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.